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Background: The size of the vertebrate eye and the retina is likely to be controlled at several stages of
embryogenesis by mechanisms that affect cell cycle length as well as cell survival. A mutation in the zebrafish out
of sight (out) locus results in a particularly severe reduction of eye size. The goal of this study is to characterize the
out
m233 mutant, and to determine whether mutations in the out gene cause microphthalmia in humans.
Results: In this study, we show that the severe reduction of eye size in the out
m233 mutant is caused by a
mutation in the zebrafish gdf6a gene. Despite the small eye size, the overall retinal architecture appears largely
intact, and immunohistochemical studies confirm that all major cell types are present in out
m233 retinae. Subtle cell
fate and patterning changes are present predominantly in amacrine interneurons. Acridine orange and TUNEL
staining reveal that the levels of apoptosis are abnormally high in out
m233 mutant eyes during early neurogenesis.
Mutation analysis of the GDF6 gene in 200 patients with microphthalmia revealed amino acid substitutions in four
of them. In two patients additional skeletal defects were observed.
Conclusions: This study confirms the essential role of GDF6 in the regulation of vertebrate eye size. The reduced
eye size in the zebrafish out
m233 mutant is likely to be caused by a transient wave of apoptosis at the onset of
neurogenesis. Amino acid substitutions in GDF6 were detected in 4 (2%) of 200 patients with microphthalmia. In
two patients different skeletal defects were also observed, suggesting pleitrophic effects of GDF6 variants. Parents
carrying these variants are asymptomatic, suggesting that GDF6 sequence alterations are likely to contribute to the
phenotype, but are not the sole cause of the disease. Variable expressivity and penetrance suggest a complex non-
Mendelian inheritance pattern where other genetic factors may influence the outcome of the phenotype.
Background
Microphthalmia, anophthalmia, and chorioretinal colo-
boma are ocular malformations that affect 1 in 3000-
4000 individuals [1-3]. In microphthalmia and
anophthalmia, one or both eyes are abnormally small or
clinically absent. Colobomata are clefts caused by absent
eye tissue, due to a failure of the optic fissure to close.
Colobomata are frequently grouped with microphthal-
mia and anophthalmia, as they are often associated with
ar e d u c t i o no fe y es i z e .T h ea e t i o l o g yo ft h e s eo c u l a r
malformations is complex, and a wide variation is seen
in phenotypic expression. Recessive, dominant and
X-linked modes of inheritance have been described, but
often sporadic and non-Mendelian inheritance patterns
are seen [4,5]. In addition, a variety of environmental
factors may be causative in certain cases, including viral
infection, such as rubella, irradiation and drug intake in
pregnancy.
Mutations in the transcription factor SOX2 are the
most prevalent monogenic cause of microphthalmia and
anophthalmia identified to date [6]. Other genes include
the transcription factors PAX6, OTX2, CHX10 and RAX
[7-10]. More recently, mutations in three members of
the transforming growth factor-b (TGF-b)s u p e r f a m i l y
(BMP4; GDF6,a l s ok n o w na sBMP13;a n dGDF3)h a v e
been associated with microphthalmia/anophthalmia
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signaling molecules play essential roles in embryonic
development [16,17]. Members of this superfamily regu-
late cell proliferation and apoptosis, and play important
roles in various processes such as the creation of dorsal-
ventral axes in the embryo, specification of the neural
crest, bone formation, and organogenesis [18-20].
A segmental deletion encompassing the GDF6 gene,
and several amino acid substitutions in GDF6 have been
identified in patients with ocular anomalies, including
coloboma and microphthalmia [13-15]. In addition, a
chromosomal rearrangement and several amino acid
substitutions in GDF6 have been detected in patients
with Klippel-Feil syndrome, a complex skeletal disorder
characterized by congenital fusion of the cervical spine,
and in patients with other skeletal defects [21,14]. Gdf6
is expressed in the dorso-temporal retina, and morpho-
lino (MO) knockdown experiments of Gdf6 in zebrafish
and Xenopus result in reduced eye size or even the
absence of optic lobes [13,22]. As these experiments
were performed using antisense compounds, it is likely
that this variability reflects imperfections of the morpho-
lino knockdown approach. In Xenopus, and to a lesser
extent in zebrafish, this phenotype is accompanied by a
disorganization of retinal layering [22,13]. In addition,
the presence of skeletal anomalies (curled or kinked
tails) was observed in a fraction of MO-treated zebrafish
embryos. The loss of Gdf6 in homozygous knockout
mice causes abnormalities in joint, ligament and carti-
lage formation, and variable ocular phenotypes [23,14].
Finally, a small eye phenotype in the zebrafish mutant
dark half
s327 was attributed to a nonsense mutation in
the gdf6a gene [24]. The authors of this work show
that gdf6a establishes dorsal-ventral positional informa-
tion in the retina and controls the formation of the reti-
notectal map.
Given conflicting results of studies in different verte-
brate model systems, the role of GDF6 in eye develop-
ment merits further investigation. We performed
analysis of the gdf6a gene in the zebrafish out
m233
mutant, characterized by a severe reduction of eye size
[25,26]. We found that the out
m233 mutation eliminates
the initiation codon in the gdf6a gene, disrupting the
function of this gene. Despite the reduction of eye size,
retinal lamination is normal in most mutant animals,
and the optic nerve appears largely unaffected. The
small eye size phenotype in out
m233 is associated with a
wave of apoptosis during early stages of development.
Other than eye size reduction, no obvious defects are
observed in the external appearance of out
m233 mutants,
including its craniofacial skeleton. out
m233 mutant
homozygotes frequently survive to adulthood and dis-
play a variable reduction of size. Other than eye defects,
we have not observed obvious abnormalities in the
appearance of swimming behavior of out
m233 mutant
homozygotes. To investigate the role of GDF6 in human
eye defects, we screened the GDF6 gene in 200 patients
suffering from microphthalmia, anophthalmia or related
abmormalities, and detected amino acid substitutions in
four of them.
Results
The out of sight
m233 phenotype
The out of sight (out)
m233 mutant was identified in a
large-scale ENU mutagenesis screen [25,26]. Out of sev-
eral small eye mutants that were isolated in this experi-
ment, out
m233 displayed the most severe phenotype
already distinguishable during day 2 of development
[26] (Figure 1). Pigmentation appears to be darker in
out
m233, compared to its wild-type siblings at 5 dpf, but
no obvious defects are observed in other organs, and
some mutant fish differentiate the swim bladder. The
majority of mutant individuals die between 5 and 10
dpf, and only a small fraction of animals survive to sev-
eral weeks of age. These individuals have grossly normal
body shapes, but feature very small eyes and in the most
extreme cases are anophthalmic (Figure 1E, F). Histolo-
gical analysis indicates that both the retina and the lens
are grossly reduced in size in out
m233 mutants (Figure
1). Although the retina is reduced in size by ~50% at 5
dpf, in most mutant individuals its overall architecture
appears grossly intact.
Positional cloning of the out
m233 mutation
Mapping analysis revealed that the out l o c u si sl o c a t e d
on chromosome 16 between markers Z6293 and Z8819
(Figure 2). This region contains around 41 annotated
genes, including gdf6a (radar, LOC566470). Sequence
analysis of gdf6a in the out
m233 mutant identified a c.1A
> G transition affecting the start codon (p.Met1Val).
This is the first ATG in the gdf6a transcript, and is pre-
ceded by a termination codon 42 bp upstream, confirm-
ing that this is the translation start site. The first ATG
following the affected start codon is located four base
pairs downstream (c.5A), and if used would result in a
shift in the open reading frame. However, that ATG
might not be used as a translation start site since it is
not embedded in a Kozak consensus sequence. Another
translation start site that is predicted to be functional by
NetStart [27] is located at position c.223A, and its use
would produce a protein in the correct reading frame
but lacking the first 74 amino acids, including the signal
peptide.
To confirm that its defects are indeed responsible for
the out
m233 mutant phenotype, we overexpressed the
wild-type gdf6a in the progeny of crosses between
out
m233 heterozygotes. This was accomplished by inject-
ing into embryos a DNA construct containing gdf6a
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gene that contains the p.Met1Val substitution was used
in these experiments as a negative control. The overex-
pression of the wild-type gdf6a produced a significant
decrease (p = 0.003, chi square) in the frequency of phe-
notypically mutant animals from ca. 20% (34/171) to 8%
(13/154). At the same time, we observed that ca. 9%
(14/155) of animals featured one small and one normal
size eye. This phenotype was entirely absent in animals
treated with the control mutant construct (0/171). We
interpret the one eye phenotype as a partial rescue of
out
m233 eye size defect.
To further test whether the p.Met1Val substitution
affects gene function, we overexpressed wild-type and
mutant Gdf6 in zebrafish using a heat-inducible promo-
ter. In agreement with previous studies [24], the overex-
pression of the wild-type Gdf6 construct frequently
results in ventral eye defects. In contrast to that, the
overexpression of the mutant gene produces ventral eye
abnormalities with a much lower frequency (Figure 2D-
F). These data are in agreement with the results of
out
m233 rescue experiments, and indicate that the p.
Met1Val substitution affects gene function. Based on
t h e s er e s u l t s ,w ec o n c l u d et h a tm u t a t i o ni nt h egdf6a
gene is responsible for small eye phenotype in the
out
m233 mutant strain.
Evaluation of cell fate in out
m233 retinae
To develop a better understanding of the mutant pheno-
type, we evaluated the number of retinal cells by count-
ing cell nuclei on sections through wild-type and gdf6a/
out
m233 retinae at 36 and 96 hpf (Figure 3). At 36 hpf,
the number of retinal cells is not statistically different in
out
m233 mutants, compared to the wild-type. At 96 hpf,
Figure 1 Phenotype of the zebrafish out of sight mutant. (A - B) Lateral views of wild-type zebrafish (A) and of the out
m233 mutant (B) at 36
hpf, 48 hpf (a1 and b1), 72 hpf (a2 and b2) and 96 hpf (a3 and b3). The out
m233 mutant is characterized by a severe reduction in eye size. No
obvious defects are observed in other organs. (C - D) Transverse plastic sections of wild-type (C) and out
m233 mutant (D) retinae at 36 hpf, 4 dpf
(c1 and d1) and 5 dpf (c2 and d2). Although the retina and lens are grossly reduced in size in out
m233 mutants, their overall architectures appear
largely intact. (E - F) An anophthalmic out
m233 homozygous mutant at ca. 2 months of age. An enlargement of the head region is shown in (F).
(G - H) A wild-type individual (G) and its microphthalmic out
m233 sibling (H) at 2.5 months of age. In A, B, and E-H, anterior is to the left.
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mutant embryos, compared to the wild type (p < 0.01
for all cell layers, Student’s t-test).
To determine whether all major cell classes are pre-
sent in out
m233 retinae, sections through wild-type and
mutant larvae were immunolabeled at 2-6 dpf using sev-
eral antibodies, including anti-carbonic anhydrase for
Müller glia [28]; anti-parvalbumin, anti-serotonin, and
anti-GABA for subsets of amacrine cells [29]; anti-Pax6
and anti-HuC/HuD for ganglion and amacrine cells
[30,31]; anti-Zpr1 for red/green cone photoreceptor
cells; anti-rod opsin for rod cells [32,33]; and anti-neu-
rolin for ganglion cells [33] (Figure 4, and data not
shown). These experiments demonstrated that all cell
classes assayed are present in out
m233 embryos in rela-
tively normal proportions, however, some of them
display aberrant patterns. For example, in ca. ~50% of
out
m233 embryos, we observed the absence of Zpr1-posi-
tive cells in some regions of the photoreceptor cell layer
(Figure 4). This defect frequently correlates with the
mislocalization of parvalbumin-positive cells (Figure 4F,
compare to the wild type in E). The most interesting
defect is present in GABA-positive amacrine cells. On
the majority of sections, the number of GABA-positive
neurons is increased in the retinal periphery and
decreased in the center of the retina (arrowheads in
Figure 4N, compare to M, graph in 4O). We have not
observed obvious defects in the ganglion cell layer or in
Muller glia. The optic nerve displays grossly normal
appearance (Figure 4B), and glial cells extend apical pro-
cesses into the photoreceptor cell layer (Figure 4L,
inset).
Evaluation of cell proliferation and apoptosis during
out
m233 eye development
A reduction of organ size can be caused, among other
reasons, by changes in the cell cycle, including a prema-
ture differentiation of proliferative precursor cells, or
increased cell death [34,35]. An increase in the length
of G1, S, or G2 phase, for example, would result in a
decrease in the frequency of cells positive for phospho-
H3, a marker of mitosis. Conversely, an increase in
M-phase length would result in an increased occurrence
of phospho-H3 positive cells. If, on the other hand, ret-
inal precursor cells are differentiating prematurely, then
neurolin, a marker of ganglion cells, the first retinal
neurons to become postmitotic [36], is likely to be
expressed earlier in the mutant, compared to the wild-
type retina. The immunolabeling of mutant and wild-
type embryos at 36 hpf with anti-phospho-histone H3
and anti-neurolin antibodies revealed that the levels of
phospho-H3 histone-positive (i.e. mitotic) nuclei relative
to all nuclei, and the appearance of neurolin-positive
ganglion cells in mutant retinae are normal (Figure 5,
and data not shown). To further confirm that the tim-
i n go fn e u r o g e n e s i si sn o ta f f e c t e di nout
m233 mutants,
we crossed the Tg(pou4f3:gap43-GFP) transgene into the
out
m233 mutant background. This transgenic line
expresses GFP in the ganglion cell layer by 42 hpf [37].
We have not observed consistent differences in the
onset of GFP expression between out
m233 mutants and
their wild-type siblings (n > 20 for both wild-type and
mutant; Figure 4H, and data not shown). This indicates
that the timing of ganglion cell neurogenesis is unlikely
to be defective in out
m233 embryos. Based on anti-phos-
pho-H3 staining, it also appears that the length of the
M-phase, relative to the rest of the cell cycle is
unchanged in the mutant. We cannot, however, exclude
the possibility that the overall cell cycle length is
affected in out
m233 animals.
Figure 2 Positional cloning of the zebrafish out of sight
mutation. (A) The out locus maps to chromosome 16 between
markers Z6293 and Z8819. Sequence analysis of the gdf6a gene
from this interval identified a mutation affecting its start codon
(c.1A > G, p. Met1Val) in mutant (C) but not wild-type (B)
individuals. SP = signal peptide, ASD = active signaling domain.
(D, E) The overexpression of wild-type (E) but not mutant (D) gdf6a
causes ventral eye defects. Shown are lateral (left panels) and
ventro-lateral (right panels) views of zebrafish larvae at 3 dpf.
Anterior is to the left, asterisks indicate the lens. (F) The frequency
of ventral eye defects, following the overexpression of wild-type or
mutant gdf6a in four independent experiments, as indicated on the
horizontal axis (1 through 4). Numbers above the bar graph indicate
sample sizes.
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be due to increased apoptotic removal of retinal cells. To
test this possibility, apoptotic cells in wild-type and
mutant embryos were visualized by staining with acridine
orange (26 hpf, not shown) or TUNEL (30, 48, 72, and
120 hpf). The levels of apoptosis are abnormally high in
out
m233 mutant eyes during early neurogenesis. Apoptosis
in the lens, a normal event in wild-type zebrafish at 24-25
hpf [38,39], persists in mutant embryos. At 30 hpf, an
obvious increase of apoptosis is seen in the lens and the
retina of mutants, compared to the wild type (Figure 6).
Apoptosis persists in and around the lens region in the
mutant at 48 hpf. By 76 hpf, on the other hand, there is
hardly any apoptotic activity visible in the mutant eye,
and a significantly larger amount of apoptosis occurs in
the wild-type retina (Figure 6). At 5dpf, few apoptotic
cells are detectable both in wild-type and mutant ani-
mals. These results suggest that the small eye phenotype
is caused by a wave of apoptosis in the mutant eye.
Mutation analysis of the GDF6 gene in patients with
microphthalmia
A cohort of 200 unrelated probands with coloboma,
microphthalmia and/or anophthalmia was screened for
mutations in the GDF6 gene. Three heterozygous
synonymous changes were identified in 11 patients
(c.93C > T/p.Ser31Ser, c.852C > G/p.Ser284Ser, and
c.936G > C/p.Ser312Ser). A heterozygous transition
(c.955G > A) leading to an amino acid substitution (p.
Ala319Thr) was identified in a patient (ID178) with iso-
lated unilateral microphthalmia. This variant was not
detected on 362 control chromosomes.
In three unrelated patients (ID66, ID136 and 792-535),
we identified a heterozygous transition (c.746C > A)
leading to an amino acid change (p.Ala249Glu) in the
GDF6 prodomain (Figure 7). Besides microphthalmia,
patient ID66 has malformed ossicles. Patient ID136 has
been diagnosed with cystic fibrosis due to mutations in
the CFTR gene, microphthalmia, cleft palate, hemiver-
tebrae, hemifacial hypoplasia, a ventriculoperitoneal
shunt for hydrocephalus, talipes, growth hormone defi-
ciency and a small pituitary gland. The third patient,
792-535, has a half-sister who was also diagnosed with
microphthalmia. The half-sister does not carry the p.
Ala249Glu variant, while the carrier father does not
have microphthalmia (Figure 7C).
Discussion
In this study, we characterized the zebrafish out
m233
mutant strain and identified a mutation in the gdf6a
Figure 3 The number of cells in wild-type and out
m233mutant retinae. (A - B) Hoechst staining of 4-μm plastic sections through the retina
of wild-type (A) and out
m233 (B) embryos at 36 hpf. (C) Diagram showing the number of nuclei that were counted in the dorsal, ventral, and
entire retina. At 36 hpf, cell numbers in mutant embryos are not significantly different from these in wild-type siblings. Cells were counted on
sections from 7 and 4 embryos for wild-type and mutant, respectively. (D - E) Hoechst staining of 4-μm plastic sections through the retina of
wild-type (D) and out
m233 (E) embryos at 96 hpf. (F) Diagram showing the number of nuclei that were counted in the ganglion cell layer (GCL),
in the inner nuclear layer (INL) and in the photoreceptor layer (PRCL). By 96 hpf, cell numbers in all these three layers are reduced in mutant
embryos, compared to the wild type (for GCL, p < 0.01; for INL and PRCL, p < 0.001; t-test). For both wild-type and mutant, cells were counted
on sections from 6 embryos. Asterisks indicate the lens, and arrowheads the optic nerve.
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m233 retinae. (A-B) Transverse sections through the retina stained with anti-neurolin antibody (red) in
wild-type (A) and out
m233 (B) embryos. The ganglion cell layer and the optic nerve display grossly normal appearance at 56 hpf. Sections were
counterstained with YoPro (green). (C-D). Anti-parvalbumin antibody (red) stains a subset of amacrine cells on transverse sections through the
retinae of wild-type (C) and out
m233 mutant (D) embryos. A displacement of some amacrine cells towards and occasionally into the
photoreceptor cell layer is observed in approximately 50% of out
m233 embryos (arrowhead in D). (E - F) Anti-paravalbumin and Zpr1 double
immunostaining (both in green) in wild-type (E) and in out
m233 mutant (F) embryos. In approximately 50% of the embryos, Zpr1-positive cells are
absent in the dorsal and/or ventral regions of the photoreceptor layer (arrowheads in F). (G - H) Images of whole embryos at 42.5 hpf. Ganglion
cells are visualized with brn3c-GFP transgene in wild-type (G) and out
m233 mutant (H) embryos. Anterior is to the left. (I -J) The Zpr1 antibody
stains red and green cones (green signal) while anti-serotonin antibody labels serotonin-positive amacrine cells (red) in wild-type (I) and out
m233
mutant (J) embryos. (K-L) Anti-carbonic anhydrase antibody (red) stains Müller glia in wild-type (K) and out
m233 mutant (L) embryos. Arrowhead
in the inset indicates the apical processes of the Muller glia, which terminate at the outer limiting membrane. (M - N) Anti-GABA antibody
(green) stains a subset of amacrine cells in wild-type (M) and out
m233 mutant (N) embryos. On the majority of sections, the number of GABA-
positive neurons is increased in the retinal periphery of out
m233 homozygotes (arrowheads). (O) Graph showing the frequency of GABA-positive
cells in the central retina. The number of cells per an arbitrary unit of distance if provided. Fewer GABA-positive cells are observed in the mutant,
compared to the wild type (p < 0.01, t-test). Blue dots represent sections. As some sections have the same frequency of GABA-positive cells, the
number of dots does not equal the number of sections. n ≥ 4 embryos for both wild-type and mutant. Asterisks mark the lens. (C-F) and (I-N)
show retinae at 5 dpf.
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size of the retina and the lens are grossly reduced in
gdf6a/out
m233 mutants, but the overall retinal architec-
ture appears largely intact. This is in contrast to other
small eye size phenotypes in zebrafish, which often exhi-
bit retinal defects in lamination or retinal degeneration
[40,26,41]. Despite eye size reduction, all cell classes
that we assayed for are present in out
m233 mutants,
although some display variable abnormalities. In ~50%
of out
m233 embryos we observed partial absence of the
photoreceptor cell layer in the dorsal and/or ventral
regions of the retina. In the regions of photoreceptor
absence, we observed a displacement of amacrine cells
towards and occasionally into the photoreceptor cell
layer. Another interesting defect is present in GABA-
positive neurons. These cells are present in abnormally
large numbers at the retinal margin at 6 dpf. As neuro-
genesis continues at the margin of the retina throughout
the lifetime of the organism and the quantity of GABA-
positive cells decreased in the central retina, this pheno-
type is most likely transient. As postmitotic GABA-
positive neurons near the marginal zone become older,
their excess is most probably eliminated by apoptosis.
Our studies suggest that a major contributing factor to
the small eye and lens size is deregulated apoptosis.
Apoptosis is a normal event during the development of
the zebrafish retina, normally occurring around 24 to 25
hpf [38]. The increased apoptosis in the out
m233 mutant
is evident at 26 hpf and persists until at least 48 hpf,
suggesting that retinal precursor cells which normally
contribute to the neural retina and lens are being elimi-
nated through apoptosis, which results in a reduction of
cell numbers in all retinal layers by 72 hpf.
While this manuscript was in preparation, the small
eye size in another zebrafish mutant (dark half
s327), was
attributed to a nonsense mutation in the gdf6a gene
[24]. The authors of this work show that gdf6a is neces-
sary to induce dorsal fate in the retina. Loss of gdf6a
prevents specification of the retinal ganglion cells with
dorsal identity and prevents innervation of the ventral
tectum. Gdf6a activates the expression of known dorsal
markers (bmp4, tbx5, tbx2b, efnb2)a n dr e p r e s s e st h e
expression of ventral fate determinant, vax2. Similar to
our observations in the out
m233 mutant, the retina of the
dark half
s327 homozygotes features a transient increase
in cell death [24]. Lamination defects have not been
reported.
Previous studies have examined the effect of GDF6
loss of function on eye development by morpholino
antisense oligonucleotide (MO) knockdown in Xenopus
and zebrafish [13,22]. A striking reduction of eye size
was observed in Xenopus embryos [22]. In zebrafish,
MO injection resulted in highly variable ocular anoma-
lies including ventral colobomata, persistent dorsal-ret-
inal groove, microphthalmia, and even anophthalmia
[13]. The retina was disorganized after MO knockdown
in Xenopus and zebrafish, and immunolabeling with
anti-XAP-1 and anti-islet-1 antibodies in Xenopus did
not detect any photoreceptor, ganglion or amacrine cells
[13,22]. This is in contrast to our findings in the out
m233
mutant, where retinal lamination is largely normal and
all cell classes are present.
MO knockdown of gdf6a in zebrafish recently identi-
fied the presence of skeletal anomalies (curled or kinked
tails), although their prevalence was much lower than
that of ocular anomalies [14]. Axial abnormalities were
also seen in Xenopus tadpoles following morpholino
injection [21]. In these studies, MO knockdown of gdf6a
did not always lead to a mutant phenotype, as signifi-
cantly reduced levels of correctly spliced gdf6a mRNA
were identified in phenotypically unaffected morphant
embryo pools [14]. In contrast to these findings, other
than eye size reduction, no obvious defects are observed
in the external appearance of out
m233 mutants, including
its craniofacial skeleton. The external morphology of
Figure 5 Cell proliferation in the out of sight retina.( A-B )
Immunolabeling of transverse cryosections through the retinae of
wild-type (A) and out
m233 mutant (B) embryos with anti-phospho-
histone H3 (red) antibodies at 36 hpf. Sections were counterstained
with YoPro (green). (C) Graph illustrating the numbers of phospho-
H3 histone-positive nuclei on sections through wild-type and
out
m233 mutant retinae as indicated. (D) Graph showing the ratio of
phospho-H3-positive cells to all cells. No differences between wild-
type and out
m233 embryos were identified. In (C - D), black dots
represent sections. As some sections have the same number of
phospho-H3-positive cells, the number of dots does not equal the
number of sections. n ≥ 10 embryos and ≥ 15 sections for both
wild-type and mutant samples. Asterisks indicate the lens, and
arrowheads the optic nerve. Dorsal is up.
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m233 mutant embryos. (A - H) Transverse cryosections through the zebrafish eye. Apoptosis is detected using the
TUNEL assay (red signal). Levels of apoptosis are abnormally high in out
m233 mutant (E-H) eyes during early neurogenesis. At 30 hpf, there is an
increase of apoptosis in the lens and the retina of mutants (E) compared to the wild-type (A). Apoptosis persists in and around the lens region
at 48 hpf (F, compare to B). By 76 hpf, hardly any apoptosis is visible in the mutant eye (G), and a significantly increased amount of apoptosis
occurs in the wild-type (C) retina, compared to the mutant. At 5 dpf, hardly any apoptotic cells are found in both the wild type (D) and the
mutant (H). (I) The amount of cell death is quantitated. The average number of apoptotic cells per section is provided. Arrowheads point to the
lens. n ≥ 9 sections from at least 3 embryos for each time point both for wild-type and mutant samples.
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s327 mutants was also inconspicuous, with the
exception of smaller eyes [24]. Similarly, we also did not
observe any defects in circulation and axial vasculature in
the out
m233 mutant, although these were reported after
MO-knockdown of gdf6a in zebrafish [13,42,43]. The dif-
ferences observed between MO-injected embryos and the
out
m233 and dark half
s327 mutant strains might be attrib-
uted to a toxic effect of the MOs or to non-specific inter-
ference of anti-gdf6a morpholinos with other genes.
Non-target related phenotypes including neuronal cell
death have been reported for 18% of MOs, even when
relatively low MO concentrations are used [44]. Mistar-
geting by MOs could be caused by the simultaneous
inactivation of an essential gene with serendipitous
homology, or perhaps by some unexpected chemical con-
taminants found in a small fraction of MO syntheses
[44]. Such nonspecific effects of morpholino knockdown
experiments can be usually excluded via rescue experi-
ments [45,46]. In the case of gdf6, rescue experiments are
difficult to perform as the overexpression of this gene
results in the ventralization of the entire embryo [22,21].
An alternative explanation for the discrepancy could be
that the out
m233 mutant may be a hypomorph that retains
some residual gdf6a function. This, however, seems unli-
kely since the out
m233 mutation disrupts the translation
start site, which will either abolish protein synthesis (if
the ATG at position c.5A is used) or produce a protein
lacking the signal peptide (if the ATG at position c.233A
is used). Such a truncated protein is unlikely to be trans-
ported to the endoplasmic reticulum and Golgi for post-
translational modifications, which include two proteolytic
cleavage steps[47]. Another defect in the zebrafish gdf6a
gene was previously reported to result in a short body
axis, a reduction of head structures, and death by 48 hpf
[48]. That mutant, however, carries a large deletion of
many genes, which could explain the more severe
phenotype.
In a previous study, a segmental deletion encompass-
ing the GDF6 gene was identified in a patient with bilat-
eral chorioretinal colobomata [13]. The patient exhibited
multiple developmental defects, including neurodevelop-
mental impairment, bilateral soft-tissue syndactyly of the
toes, and an atrial septal defect. Besides GDF6,3 0o t h e r
genes are also lost in the deletion, which could contri-
bute to the range of developmental defects seen in this
patient.
Mutations in GDF6 have also been recently reported
in patients with Klippel-Feil syndrome, a complex skele-
tal disorder characterized by congenital fusion of verteb-
rae within the cervical spine [21]. A chromosomal
inversion segregated with the disease in a 5-generation
family exhibiting an autosomal dominant inheritance
pattern. Besides fusion of the vertebral bodies and lami-
nae, the affected family members had scoliosis of the
thoracic and lumbar spine, fusion of the carpal and tar-
sal joints, and restricted elbow movement. No DNA loss
was evident at the inversion boundaries, and no coding
genes appeared to be disrupted. The proximal inversion
breakpoint was located 623 kb 3’of GDF6. The authors
s u g g e s tt h a tt h ed i s e a s ei sa s s o c i a t e dw i t hGDF6,p e r -
haps by disruption of long-range enhancer elements,
since the skeletal anomalies in this family correspond
with the phenotype observed in Gdf6 knockout mice
[23]. In these mice, defects in joint, ligament, and carti-
lage formation were seen in the wrist, the ankle, the
middle ear, and the coronal suture between bones in the
skull [23]. Analysis of GDF6 in 127 individuals with
Klippel-Feil syndrome identified two missense variants,
Figure 7 GDF6 analysis in patients with microphthalmia,
anophthalmia and coloboma. (A) Two different heterozygous
amino acid changes, p.Ala249Glu and p.Ala319Thr, were detected in
four unrelated individuals. (B) The sequence of the heterozygous p.
Ala249Glu variant in patient 792-535. (C) The affected half-sib of
patient 792-535 does not carry the p.Ala249Glu variant, while it was
detected in the unaffected father.
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were described in these patients [21]. The two variants
were not identified on 708 control chromosomes [21].
In a recent study, 489 patients with ocular anomalies
and 81 patients with vertebral segmentation defects
were screened for GDF6 mutations [14]. The authors
identified four amino acid substitutions associated with
ocular phenotypes, two with a skeletal phenotype, and
one alteration (p.Ala249Glu) was identified in 3 pro-
bands who either had ocular or skeletal phenotypes.
These variants were not detected on at least 366 control
chromosomes. For three variants, segregation analysis
showed the presence of the alteration in an unaffected
parent indicating incomplete penetrance. The effect of
two amino acid substitutions, p.Ala249Glu and p.
Lys424Arg, were evaluated with SOX9 reporter gene
assays and Western blot analysis. Mutant GDF6 was less
effective in activating SOX9 reporter gene activity com-
pared to wild-type GDF6. By Western blot analysis it
was shown that the level of secreted mature GDF6 was
reduced with p.Ala249Glu and p.Lys424Arg [14].
Screening of 50 patients with ocular anomalies recently
identified GDF6 mutations in four (8%) patients[15].
Three of these patients carried the p.Ala249Glu variant.
In this study, we identified two different amino acid
substitutions, p.Ala249Glu and p.Ala319Thr, in four
(2%) of 200 patients with ocular malformations.
Although both variants are conserved among several
species, neither is conserved in zebrafish gdf6a.T h e r e -
fore it was not possible to perform rescue experiments
in the out
m233 mutant to determine the pathogenic
potential of these variants. Interestingly, the p.Ala249-
Glu variant has been associated both with Klippel-Feil
syndrome and with ocular anomalies [21,14,15]. The
variant was detected on 8 of a total of 1478 chromo-
somes of patients with ocular malformations [13-15],
and not on a total of 1074 control chromosomes [14,21]
(Fisher’se x a c tt e s t ,p-value 0.01), strongly suggesting
that it is pathogenic. Parents carrying this variant are
asymptomatic, suggesting that GDF6 sequence altera-
tions are likely to contribute to the phenotype, but are
not the sole cause of the disease. This is confirmed by
the fact that the affected sib of one of the patients in
our study does not carry the p.Ala249Glu variant, indi-
cating that other factors contribute to the disease.
Besides microphthalmia, one patient in our study carry-
ing the p.Ala249Glu variant has malformed ossicles.
Interestingly, middle ear defects were also observed in
Gdf6
-/- mice, suggesting that the p.Ala249Glu variant
could contribute to the ocular and middle ear defects in
this patient. Finally, another microphthalmic patient in
our study who carries the p.Ala249Glu variant has sev-
eral skeletal anomalies, including cleft palate, hemiver-
tebrae and talipes. Microphthalmia in combination with
cleft lip and palate have recently been described in
another patient carrying the p.Ala249Glu variant [15],
suggesting that the extra-ocular defects might also be
attributed to the p.Ala249Glu variant.
Conclusions
This study confirms the essential role of GDF6 in the
regulation of vertebrate eye size. The reduced eye size in
the zebrafish gdf6a/out
m233 mutant is likely to be caused
by a transient wave of apoptosis at the onset of neuro-
genesis. Amino acid substitutions in GDF6 were
detected in four patients with microphthalmia. In two
patients different skeletal defects were observed, sug-
gesting pleitrophic effects of p.Ala249Glu. Variable
expressivity and penetrance suggest a complex non-
Mendelian inheritance pattern where other genetic fac-
tors may influence the outcome of the phenotype.
Methods
Animals
The maintenance and breeding of zebrafish strains and
staging of embryonic development were performed as
described previously [49,50]. All animal protocols were
approved by the MEEI and Tufts University animal care
committees. Embryos were observed using an Axioscope
microscope (Zeiss, Thornwood, NY) or a Leica (Deer-
field, IL) MZ12 dissecting microscope. Images were
recorded with digital cameras, and processed using
Adobe Photoshop software. The out
m233 mutant strain
was originally recovered in a large-scale N-ethyl-N-
nitrosurea (ENU) mutagenesis screen [25,26]. To visua-
lize ganglion cells, we used the Tg(pou4f3:gap43-GFP)
trangenic line [37].
Histology
Zebrafish larvae were raised to the desired age and fixed
in 4% paraformaldehyde (PFA) in PBST overnight at 4°C.
Embedding, sectioning, and staining were performed as
described previously [51,52]. Sections were examined
using an Axioscope Microscope (Zeiss) and images were
recorded using an AxioCam digital camera (Zeiss).
Positional cloning
A map cross was set up between heterozygous G0 car-
riers of the out
m233 allele (AB genetic background) and
wild-type WIK strain homozygotes. To determine the
position of the out locus in the genome, we used a
p a n e lo f9 6F 2d i p l o i de m b r y o so b t a i n e dv i ai n c r o s s i n g
of F1 animals.
Bulk segregant mapping analysis was performed by the
Mutant Mapping Facility at the University of Louisville
on DNA isolated from the mutant embryos http://www.
biochemistry.louisville.edu/zfmapping/index.html. Posi-
tional candidate genes were selected based on the
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Center UK, and UCSC Genome Browser, University of
California at Santa Cruz). Search for mutations was per-
formed by RT-PCR of RNA isolated from wild-type and
out
m233 embryos, and by PCR on genomic DNA. PCR
products were purified using the QIAquick PCR purifi-
cation kit (Qiagen) and analyzed by direct sequencing.
The effect of the mutation, which affects the translation
start site, was evaluated with NetStart 1.0 [27].
Rescue and overexpression experiments
The wild-type gdf6a gene was previously cloned into the
pNG6 vector under the control of a heat-shock promo-
ter [24]. The p.Met1Val mutation was introduced by
site-directed mutagenesis of the wild-type gdf6a con-
struct with phusion DNA polymerase (Finnzymes,
Espoo, Finland). The wild-type and mutant constructs
were injected into zebrafish embryos at the one-cell
stage using standard approaches [53]. Expression was
activated via a 1 hour heat shock at the 12 somite stage.
The eye phenotype was evaluated at 3 and 5 dpf.
Staining of nuclei
To count cells in retinal layers, wild-type and mutant
embryos were fixed in 4% PFA at 36 and 96 hpf, and
embedded in JB-4 resin (Polysciences), according to the
manufacturer’s instructions. Subsequently, 4-μm sections
were collected on microscope slides, immersed in
Hoechst 33258 solution (Molecular Probes; 1 mg/ml in
PBS) for 10 min, and washed in PBS for 1 h. Alterna-
tively, YoPro (Molecular Probes) was diluted 1:5,000 in
PBST and used to stain frozen sections for 10 min. Sec-
tions were analyzed using UV illumination.
Analysis of cell death
Two methods were used to evaluate apoptotic cell
death: acridine orange staining and TUNEL. To apply
the first method, embryos were dechorionated, and
placed in 5 mg/ml acridine orange (acridinium chloride
hemi-zinc chloride; Sigma) in E3 medium [54] for 30
min. Embryos were then washed in E3 medium and
viewed using UV illumination on an upright microscope.
For TUNEL detection of cell death, zebrafish larvae
were fixed in 4% PFA, cryoprotected in sucrose, and
cryosectioned at 14 μm. Following two washes, 10 min
each, in 50 mM PBS (pH 7.4), sections were treated
with Proteinase K (Roche Applied Sciences, Indianapolis,
I N )f o r1 0m i na tt h ec o n c e n t r a t i o no f2μg/ml in 50
mM Tris/HCl buffer, pH 8. Subsequently, sections were
rinsed 3 times in 50 mM Tris/HCl buffer, incubated
with 70% ethanol/30% acetic acid solution at -20°,
washed 5 times, 5 min each, in 50 mM Tris/HCl buffer,
and treated with blocking solution, containing (v/v in
PBST) 10% normal goat serum, and 0.5% Triton X-100
(30 min, room temperature). Finally, sections were incu-
bated with TUNEL reaction mixture (Roche) at 37°for
several hours according to manufacturer’si n s t r u c t i o n s .
To detect apoptotic nuclei, sections were rinsed in 50
mM PBS for 10 min, coverslipped, and analyzed on a
Leica SP2 confocal microscope equipped with a 40x
lens. Digital images were processed with Adobe Photo-
shop Software and used to obtain counts of apoptotic
cells.
Immunohistochemistry
Antibody staining was perform e do nf r o z e ns e c t i o n sa s
described in previous publications [51,52,29]. The fol-
lowing primary antibodies and dilutions were used:
rabbit anti-phospho-H3 histone (1:200, Upstate Bio-
technology); mouse monoclonal anti-neurolin (1:25,
Zebrafish International Resource Center); rabbit poly-
clonal anti-carbonic anhydrase (1:250, gift of Paul Lin-
ser, Whitney Laboratory, S t .A u g u s t i n e ,F L ) ;m o u s e
monoclonal anti-parvalbumin (1:250, Chemicon);
mouse monoclonal anti-HuC/HuD (1:20, Molecular
Probes); mouse monoclonal Zpr1 (1:250, Zebrafish
International Resource Center); rabbit polyclonal anti-
serotonin (1:250, Sigma); rabbit polyclonal anti-tyrosine
hydroxylase (1:250, Chemicon); rabbit polyclonal anti-
GABA (1:500, Sigma); and rabbit polyclonal anti-PAX6
(1:200, Covance). The anti-serotonin and anti-Pax6
antibodies required citrate treatment prior to blocking
in normal goat serum [29]. After staining, sections
were imaged using Leica SP2 confocal microscope
equipped with a 40x lens. Digital images were pro-
cessed with Adobe Photoshop Software.
Patient samples and mutation analysis
Informed consent was obtained from all participants in
this study in accordance with the local Ethic Boards in
the respective institutions where they were examined.
Blood samples were collected, and genomic DNA was
isolated by standard protocols. The coding region and
splice junctions of the two exons of GDF6 were
screened in 200 patients with coloboma, microphthalmia
or anophthalmia by automated sequencing [21]. PCR
products were treated with ExoSAP-IT (USB) or purified
with 96-wells NucleoFast purification plates (Machery-
Nagel) before automated sequencing. All mutations and
polymorphisms were confirmed by a second round of
PCR amplification.
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